{"id":"W2781073107","doi":"10.1136/lupus-2017-000239","title":"Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments","year":2017,"lang":"en","type":"review","venue":"Lupus Science & Medicine","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"AstraZeneca","keywords":"Medicine; Disease; Belimumab; B-cell activating factor; Immunology; Clinical trial; Drug development; Immune system; Immune dysregulation; Bioinformatics; Intensive care medicine; Drug; Pharmacology; Internal medicine; B cell; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002180043,0.0003442937,0.001425248,0.000344331,0.0008781264,0.00004656639,0.0004868804,0.0001089572,0.00001217125],"category_scores_gemma":[0.0006718207,0.0001588142,0.0001139492,0.0002809112,0.001411333,0.0001053977,0.0001168583,0.0001797762,6.171851e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001941268,"about_ca_system_score_gemma":0.001252973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000770335,"about_ca_topic_score_gemma":0.00001774892,"domain_scores_codex":[0.9976224,0.00002833123,0.0007408072,0.0005651676,0.0006256073,0.0004176478],"domain_scores_gemma":[0.9972075,0.0009687567,0.0005673871,0.0006583754,0.000387788,0.0002101468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001981988,0.00006191708,0.0002465155,0.0138281,0.0001568552,2.123375e-7,0.004551562,3.716045e-9,0.00002172436,0.0002138109,0.001326395,0.9795731],"study_design_scores_gemma":[0.002102659,0.0001871307,0.0000302678,0.02265221,0.0007444122,0.0008386572,0.002021826,0.00003487901,0.000005118458,0.00002188343,0.9712282,0.000132786],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001361647,0.9890314,0.0008754212,0.002556014,0.002360468,0.004877441,0.00007947955,0.00001405465,0.00006957068],"genre_scores_gemma":[0.00003299047,0.9933376,0.003642789,0.000020438,0.0006331092,0.001090066,0.00007185743,0.00003107042,0.00114002],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9794403,"threshold_uncertainty_score":0.6753927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2452857687171864,"score_gpt":0.4797586957284955,"score_spread":0.2344729270113091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}